In 2019, Sadik and coworkers reported an anti-the shed ectodomain of BP180 (LAD-1) IgG-positive, anti-BP180 NC16A IgG-negative BP in a patient treated with nivolumab for metastatic melanoma [19]. The gene discussed is COL17A1; the disease is metastatic melanoma.